Instrument Inactif

Autres langues MICROMET

Actions

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

26/01/12	Amgen, Inc. : Amgen rate le consensus de peu au 4e trimestre	RE
26/01/12	Amgen, Inc. : Amgen veut racheter Micromet pour 1,16 milliard de dollars	RE

Autres langues

07/03/12	Micromet Inc. : Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
02/03/12	Micromet Inc. : Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet, Inc. and Commencement of Subsequent Offering Period
15/02/12	Micromet Inc. : Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet
03/02/12	Micromet Inc. : Buyout Offer for Micromet Triggers Shareholder-Claim Investigation by Goldfarb LLP Securities Attorneys
02/02/12	Micromet Inc. : Bull & Lifshitz, LLP Announces Investigation of Micromet, Inc.
28/01/12	Micromet Inc. : Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.
28/01/12	Micromet Inc. : The Law Firm of Weiss & Lurie Investigates Micromet, Inc.
27/01/12	Micromet Inc. : Harwood Feffer LLP Announces Investigation of Micromet Inc.
27/01/12	Micromet Inc. : Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Micromet, Inc.
27/01/12	Micromet Inc. : Robbins Umeda LLP Announces an Investigation of Micromet, Inc.
27/01/12	Micromet Inc. : Finkelstein Thompson LLP Announces Investigation of Micromet, Inc.
26/01/12	Micromet Inc. : Pomerantz Law Firm Investigates Claims on Behalf of Investors of Micromet, Inc.
26/01/12	Micromet Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Micromet, Inc. in Connection with the Sale of the Company to Amgen Inc.
26/01/12	Micromet Inc. : Micromet, Inc. Investor Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Micromet Concerning the Sale of MITI to Amgen
26/01/12	Micromet Inc. : Law Firm Brower Piven Announces Investigation of Micromet, Inc.
26/01/12	Micromet Inc. : Amgen to Acquire Micromet
09/01/12	Micromet Inc. : Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab
12/12/11	Micromet Inc. : Micromet’s Blinatumomab Produces High Rate of Durable Hematologic Complete Remissions in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia
12/12/11	Micromet Inc. : Micromet's Blinatumomab Produces High Rate of Durable Hematologic Complete Remissions in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia
11/12/11	Micromet Inc. : Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients
11/12/11	Micromet Inc. : Micromet's Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients
05/12/11	Micromet Inc. : Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
28/11/11	Micromet Inc. : Micromet Initiates Global Phase 2 Trial of Blinatumomab in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
23/11/11	Micromet Inc. : Micromet to Present at the 2011 Piper Jaffray Health Care Conference
08/11/11	Micromet Inc. : Micromet Reports Third Quarter 2011 Financial Results